Answers are grounded in this paper and cite their sources.
Eager to replace the current tuberculosis vaccine, scientists hope to push a slew of promising candidates through clinical trials—if the money can be found.
No takes yet. Share an insight, caveat, or question.
Kai Kupferschmidt (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: